Investors

Corporate Profile

Collegium Pharmaceutical is building a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. We are growing our portfolio of differentiated medications to treat serious medical conditions. We are proud of our leadership in responsible pain management, with a portfolio of products addressing severe and persistent pain, and our expansion into neurology with a medicine for attention deficit hyperactivity disorder (ADHD). Each of our products represents meaningful innovation and, together, reflect our commitment to leadership across indications for the benefit of people and their caregivers.